- Home
- AMWD vs IMNM Comparison
AMWD vs IMNM Comparison
Compare AMWD & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMWD
- IMNM
- Stock Information
- Founded
- AMWD 1980
- IMNM 2006
- Country
- AMWD United States
- IMNM United States
- Employees
- AMWD N/A
- IMNM N/A
- Industry
- AMWD Forest Products
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- AMWD Basic Materials
- IMNM Health Care
- Exchange
- AMWD Nasdaq
- IMNM Nasdaq
- Market Cap
- AMWD 940.7M
- IMNM 945.8M
- IPO Year
- AMWD N/A
- IMNM 2020
- Fundamental
- Price
- AMWD $67.61
- IMNM $8.99
- Analyst Decision
- AMWD Buy
- IMNM Strong Buy
- Analyst Count
- AMWD 3
- IMNM 8
- Target Price
- AMWD $70.00
- IMNM $24.75
- AVG Volume (30 Days)
- AMWD 189.7K
- IMNM 1.1M
- Earning Date
- AMWD 08-26-2025
- IMNM 11-12-2025
- Dividend Yield
- AMWD N/A
- IMNM N/A
- EPS Growth
- AMWD N/A
- IMNM N/A
- EPS
- AMWD 5.62
- IMNM N/A
- Revenue
- AMWD $1,653,503,000.00
- IMNM $12,589,000.00
- Revenue This Year
- AMWD N/A
- IMNM N/A
- Revenue Next Year
- AMWD $4.06
- IMNM $154.73
- P/E Ratio
- AMWD $12.03
- IMNM N/A
- Revenue Growth
- AMWD N/A
- IMNM 16.74
- 52 Week Low
- AMWD $50.00
- IMNM $5.15
- 52 Week High
- AMWD $104.28
- IMNM $16.55
- Technical
- Relative Strength Index (RSI)
- AMWD 56.89
- IMNM 43.08
- Support Level
- AMWD $64.25
- IMNM $9.01
- Resistance Level
- AMWD $70.07
- IMNM $9.63
- Average True Range (ATR)
- AMWD 2.38
- IMNM 0.71
- MACD
- AMWD -0.06
- IMNM -0.07
- Stochastic Oscillator
- AMWD 51.62
- IMNM 16.37
About AMWD American Woodmark Corporation
American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.